cis(−)-2,3-dihydro-3-(4-methylpiperazinylmethyl)- 2-phenyl-1,5-benzothiazepin-4(5H)-one monohydrochloride and its butylbromide as M1-receptor antagonists
- 1 January 1987
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 18 (1), 91-93
- https://doi.org/10.1016/0306-3623(87)90176-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drugEuropean Journal of Pharmacology, 1985
- Effects of cyclic AMP and protein kinase on calcium uptake in a microsomal fraction from guinea pig taenia caecumBiochemical Pharmacology, 1983
- A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a schild-plot with apparent slope unityNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Effects of Nonspecific Smooth Muscle Relaxants and Ca–Blocker on Ca–Release and Ca–Binding in Microsomal Fractions from Rabbit Taenia ColiThe Japanese Journal of Pharmacology, 1980
- Synaptic plasma membranes from rat brain synaptosomes: Isolation and partial characterizationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951